-
公开(公告)号：US20080033043A1
公开(公告)日：2008-02-07
申请号：US11762840
申请日：2007-06-14
Applicant: Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Saleh
Inventor： Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Saleh
IPC: A61K31/19 , A61K31/135 , A61P25/00 , C07C211/00 , C07C69/76
CPC classification number: A61K9/0004 , A61K9/2027 , A61K9/28 , A61K9/2846 , A61K9/2866 , A61K9/2886 , A61K31/135 , A61K31/137 , C07B2200/13 , C07C225/16
Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
-
公开(公告)号：US20070293584A1
公开(公告)日：2007-12-20
申请号：US11766251
申请日：2007-06-21
Applicant: Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Saleh
Inventor： Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Saleh
CPC classification number: A61K9/0004 , A61K9/2027 , A61K9/28 , A61K9/2846 , A61K9/2866 , A61K9/2886 , A61K31/135 , A61K31/137 , C07B2200/13 , C07C225/16
Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
Abstract translation: 本发明涉及包含安非他酮盐的药物组合物，制剂和药物，特别是包含有效量的安非他酮氢溴酸盐的改性释放片剂，以及使用安非他酮盐来制备治疗病症的药物。
-
公开(公告)号：US20080274181A1
公开(公告)日：2008-11-06
申请号：US11930644
申请日：2007-10-31
Applicant: Paul Maes , Werner Oberegger , Mohammad Ashty Saleh
Inventor： Paul Maes , Werner Oberegger , Mohammad Ashty Saleh
IPC: A61K9/24
CPC classification number: A61K31/137 , A61K9/2013 , A61K9/284 , A61K9/2846 , A61K9/2866 , A61K9/2886
Abstract: Bupropion hydrobromide formulations as well as their use for the treatment of conditions is described.
Abstract translation: 描述了安非他酮氢溴酸盐制剂及其用于治疗病症的用途。
-
公开(公告)号：US20080038345A1
公开(公告)日：2008-02-14
申请号：US11774109
申请日：2007-07-06
Applicant: Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Saleh
Inventor： Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Saleh
IPC: A61K9/22 , A61K31/135 , A61P25/00
CPC classification number: A61K9/0004 , A61K9/2027 , A61K9/28 , A61K9/2846 , A61K9/2866 , A61K9/2886 , A61K31/135 , A61K31/137 , C07B2200/13 , C07C225/16
Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
-
公开(公告)号：US20080057120A1
公开(公告)日：2008-03-06
申请号：US11759413
申请日：2007-06-07
Applicant: Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Saleh
Inventor： Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Saleh
IPC: A61K9/20 , A61P25/00 , C07C211/00
CPC classification number: A61K9/0004 , A61K9/2027 , A61K9/28 , A61K9/2846 , A61K9/2866 , A61K9/2886 , A61K31/135 , A61K31/137 , C07B2200/13 , C07C225/16
Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
-
Patent Agency Ranking
公开(公告)号：US20080039441A1
公开(公告)日：2008-02-14
申请号：US11762820
申请日：2007-06-14
Applicant: Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Saleh
Inventor： Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Saleh
IPC: A61K31/55 , A61K31/135 , A61K31/34 , A61K31/38 , A61P25/00 , A61K31/445 , A61K31/497 , A61K31/517
CPC classification number: A61K9/0004 , A61K9/2027 , A61K9/28 , A61K9/2846 , A61K9/2866 , A61K9/2886 , A61K31/135 , A61K31/137 , C07B2200/13 , C07C225/16
Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
Abstract translation: 本发明涉及包含安非他酮盐的药物组合物，制剂和药物，特别是包含有效量的安非他酮氢溴酸盐的改性释放片剂，以及使用安非他酮盐来制备治疗病症的药物。
-
公开(公告)号：US20070281012A1
公开(公告)日：2007-12-06
申请号：US11762368
申请日：2007-06-13
Applicant: Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Saleh
Inventor： Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Saleh
Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
-
公开(公告)号：US20070269516A1
公开(公告)日：2007-11-22
申请号：US11751785
申请日：2007-05-22
Applicant: Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Saleh
Inventor： Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Saleh
CPC classification number: A61K9/0004 , A61K9/2027 , A61K9/28 , A61K9/2846 , A61K9/2866 , A61K9/2886 , A61K31/135 , A61K31/137 , C07B2200/13 , C07C225/16
Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
-
公开(公告)号：US20080075774A1
公开(公告)日：2008-03-27
申请号：US11834848
申请日：2007-08-07
Applicant: Robert WILLIAMS , Peter SILVERSTONE
Inventor： Robert WILLIAMS , Peter SILVERSTONE
IPC: A61K31/135 , A61K33/14 , A61K9/24 , A61K9/28 , A61P25/08
CPC classification number: A61K31/135 , A61K9/2846 , A61K9/2866 , A61K9/2886 , A61K33/00 , A61K2300/00
Abstract: Bupropion hydrobromide formulations as well as their use for the treatment of conditions is described.
-
公开(公告)号：US20080051606A1
公开(公告)日：2008-02-28
申请号：US11755946
申请日：2007-05-31
Applicant: Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Saleh
Inventor： Werner Oberegger , Fang Zhou , Paul Maes , Stefano Turchetta , Graham Jackson , Pietro Massardo , Mohammad Saleh
IPC: C07C211/27
CPC classification number: A61K9/0004 , A61K9/2027 , A61K9/28 , A61K9/2846 , A61K9/2866 , A61K9/2886 , A61K31/135 , A61K31/137 , C07B2200/13 , C07C225/16
Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
-
-
-
-
-
-
-
-
-
Search Results
12
records
(took 0.047 seconds)
